Lobby organisation
BioNTech SE
Company · Health & pharma · HQ: Germany · Transparency Register entry
As of 8 October 2026, BioNTech SE appears in 3 declared MEP meetings (3 different MEPs), most often with Socialists & Democrats.
In their own words
“Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals.”
Read the rest of the statementShow less of the statement
“Its broad portfolio of oncology product candidates aiming to address the full continuum of cancer includes mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies. Based on its deep expertise in mRNA development and in-house manufacturing capabilities, BioNTech and its collaborators are researching and developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 3 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2024. Bar length is relative to its busiest year (2 in 2023).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 3 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 16 Jan 2024 | Tomislav Sokol | Pharmaceutical legislation |
| 30 Oct 2023 | Laura Ballarín Cereza | Pharmaceutical Package (Directive) |
| 18 Oct 2023 | Tiemo Wölken | Pharma Revision - Directive (staff level) |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.